Intervention Protocol

Alemtuzumab for multiple sclerosis

  1. Rachel Riera1,*,
  2. Gustavo Porfirio1,
  3. Cristine R Migliorini2,
  4. Maria R Torloni1

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group

Published Online: 8 JUL 2014

Assessed as up-to-date: 15 JUN 2014

DOI: 10.1002/14651858.CD011203


How to Cite

Riera R, Porfirio G, Migliorini CR, Torloni MR. Alemtuzumab for multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD011203. DOI: 10.1002/14651858.CD011203.

Author Information

  1. 1

    Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde, Brazilian Cochrane Centre, São Paulo, SP, Brazil

  2. 2

    Matrix Serviços Empresariais Ltda, Translations, São Paulo, São Paulo, Brazil

*Rachel Riera, Brazilian Cochrane Centre, Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde, Rua Borges Lagoa, 564 cj 63, São Paulo, SP, 04038-000, Brazil. rachelriera@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the safety and effectiveness of alemtuzumab used alone or associated with other treatments to decrease disease activity in patients with any form of MS.